Understanding The Acute Interventions for Complicated Pleural Effusions

Abstract

Pleural effusion affects approximately 1.5 million individuals in the U.S. annually. A significant subset of these cases evolves into complicated parapneumonic effusions due to bacterial infections, intense inflammation, or other causal factors, presenting considerable diagnostic and therapeutic challenges. If untreated, the condition's sequential progression can culminate in restrictive respiratory dysfunction. This review examines the diverse interventions available for diagnosing and treating complicated pleural effusions. The therapeutic spectrum ranges from minimally invasive procedures such as thoracentesis and Intrapleural Enzymatic/Fibrinolytic Therapy (IPET) to surgical interventions, including Video-assisted Thoracoscopic Surgery (VATS) for pleurodesis and pleurectomy/decortication, and open pleurectomy/decortication. Notably, the combined use of agents in IPET presents a significant advancement, especially for patients unsuitable for surgery. Furthermore, VATS emerges as a promising, less invasive surgical alternative, and the role of pleurectomy/decortication in managing malignant mesothelioma becomes more pronounced, offering advantages over other surgical modalities. The diagnostic and therapeutic landscape for complicated pleural effusions is vast and continues to evolve, with an increasing emphasis on minimizing invasiveness and optimizing patient outcomes. As clinical approaches diversify and improve, ensuring patient-centric care becomes paramount. The future of this domain rests on refining current practices and further investigating newer interventions to elevate patient outcomes.